To the Editor,
An oral food challenge (OFC) is the gold standard for diagnosis of food
allergy, though skin prick tests (SPT) and specific IgE (sIgE) are both
used to aid in the initial diagnosis and to track sensitization, despite
their poor specificity and correlation with clinical
reactivity1. Recent studies have suggested that
basophil activation tests (BATs) might have higher sensitivity and
specificity when compared to SPT and sIgE2-6. However,
BATs remain heterogeneous with regard to the assay protocol, markers of
basophil activation, and criteria for positive
results7.
We performed a small, exploratory prospective study to evaluate the
diagnostic potential of BATs to distinguish between food tolerance and
allergy to peanut, cow’s milk, and/or hen’s egg. We hypothesized that
the combination of basophil activation markers CD63 and CD203c would be
superior to either alone. The study was approved by the Colorado
Multiple Institutional Review Board.
We enrolled patients between 4 months and 17 years of age, who were
undergoing evaluation for peanut, cow’s milk, and/or hen’s egg allergy.
Patients and their parents completed a survey assessing their exposure
history to peanut, cow’s milk, and hen’s egg. Heparinized whole blood
was obtained from each patient. All samples were stimulated for 20
minutes with phosphate-buffered saline (PBS, negative control),
anti-FcεR1 and anti-IgE (positive controls), 10-fold dilutions each of
peanut, cow’s milk, and whole hen’s egg extracts (50 μg/mL to 0.5 μg/mL)
and 10-fold dilutions of Ara h2 (10 μg/mL to 0.1 μg/mL). Samples were
placed on ice to halt basophil activation and stained with antibodies
for CD45, CD63, and CD203c. Following acquisition on a Navios flow
cytometer, basophil (identified as
SSClow/CD45+/CD203c+, figure 1 panel a and b)
expression of CD63 and CD203c was analyzed using Kaluza (Beckman
Coulter). The percentage of basophils with elevated expression of CD63
and/or CD203c was quantified. Samples with no basophil response to
positive controls were categorized as ‘non-responders’. Flow cytometry
results were compared to the clinical diagnosis in patients who (1)
underwent an OFC or (2) indicated on the survey that the specific
allergen is regularly consumed in their diet without symptoms (food
tolerant controls). The highest allergen concentrations resulted in
non-specific CD63 and/or CD203c upregulation, therefore only the two
lower allergen concentrations were used to evaluate BAT performance.
Of the 21 patients undergoing evaluation for food allergy who were
enrolled in our study, blood samples were obtained from 19 patients. Two
of the patients (11%) were ‘non-responders’. Eight OFCs were performed
in our study patients and regular food tolerance based on survey results
was reported to peanut, cow’s milk, and hen’s egg in 2, 12, and 5
patients, respectively.
Seven negative food challenges were performed in six patients. Five of
the six patients had previously been diagnosed with food allergies based
on a history of reaction and sensitization. One patient was diagnosed
with a food allergy based on sensitization, without a history of food
reaction. At the time of food challenge, five of the six patients
remained sensitized to the foods. Significant basophil upregulation was
not observed in all six patients.
Expression of CD63 and CD203c on activated basophils was not equal for
all patients. After activation with the positive control, five of the 19
patients had a differential expression of CD203 and CD63 by 30% or more
(absolute difference of percentage of basophils expressing the marker).
Of these, two patients were ‘non-responders’ based on expression of
CD63, but not CD203c. Similarly, large difference in expression of CD203
and CD63 occurred after stimulation with food allergens (Table 1).
We present below, two cases that best highlight the complementary use
CD63 and CD203c and potential clinical uses of BATs.
Case 1:
A female patient presented to our clinic at 16 months of age with
symptoms of immediate vomiting after each ingestion of cow’s milk.
Testing revealed a bidirectional SPT wheal of 4x2 mm and cow’s milk sIgE
of 32.3 kUA/L and she was diagnosed with cow’s milk
allergy. At her follow up appointment at 31 months of age, her parents
reported she was accidentally exposed to a spoon of cow’s milk without a
reaction. Repeat testing demonstrated cow’s milk bidirectional SPT wheal
of 6x4mm and sIgE of 31.4 kUA/L. She tolerated an OFC to
cow’s milk.
BAT upregulation of CD63 was insignificant following stimulation with
the two lower concentrations of cow’s milk allergen whereas upregulation
of CD203c was minimal at the lowest concentration of cow’s milk allergen
and increased relative to baseline at the intermediate concentration
(Figure 1).
Case 2:
A 9-year-old boy developed difficulty swallowing and breathing after
eating a candy containing peanuts. He was treated in the emergency
department for anaphylaxis and referred for follow up in our clinic. The
patient had a history of peanut and hen’s egg allergies. He had
tolerated an OFC to peanut at 5 years of age, but never introduced it
into his diet. He had not introduced egg into his diet since an allergic
reaction at 2 years of age. SPT at our clinic revealed bidirectional
wheals to peanut and hen’s egg of 4x2mm and 4x4mm respectively. sIgE
levels to peanut and egg were 4.62 kUA/L and 2.48
kUA/L respectively. He tolerated an OFC to peanut and
hen’s egg.
CD203c upregulation was insignificant following stimulation with the two
lower concentrations of peanut and hen’s egg allergens, and Ara h2. This
patient’s basophils did not upregulate CD63 following stimulation with
the positive controls (Figure 2), therefore, allergen-specific CD63
response could not be assessed.
Our two cases highlight the potential benefit of multiple basophil
activation markers. For case 1, CD63 was a more accurate marker of
tolerance to milk allergen whereas case 2 was a ‘non-responder’ based on
absence of CD63 upregulation, however, analysis of CD203c upregulation
in this patient enabled interpretation of BAT results.
Our results add to the growing body of literature, suggestive of the
clinical utility of BATs in understanding tolerance to food allergens.
In both cases, the BATs correctly predicted tolerance to foods despite a
history of food allergy and persistent sensitization. While previous
reports on BATs have concentrated on the potential to avoid OFCs in
patients with BATs above an established threshold, our cases suggest a
different purview on the context of use of BATs– to identify patients
with history of food allergies who may have developed tolerance, despite
persistent elevations in sIgE and SPT 2,8,9. These
patients may therefore benefit from OFCs, and BATs may be a confirmatory
test that indicates the OFC has a stronger likelihood of success
Our case series is limited by the small number of patients who underwent
OFCs and will benefit from ongoing study to better determine the
clinical utility of BAT in the aforementioned context. However, close
examination of these two cases effectively highlights (1) the potential
benefit of evaluating multiple basophil markers and (2) the potential to
identify sensitized but food tolerant patients with BAT, as a tool that
helps select for OFC candidates more likely to have successful outcomes.